On January 3, 2025, Morgan Stanley Asia Limited (MSAP) conducted a transaction of derivative warrants for PA GOODDOCTOR (Ping An Health Medical Technology Co., Ltd.) through Morgan Stanley Hong Kong Limited (MSHK). As a designated market maker approved by the Hong Kong Stock Exchange, MSHK sold 100,000 shares on behalf of MSAP for a total amount of 16,500 HKD, with a price of 0.1650 HKD per share; at the same time, it bought 152,000 shares for a total amount of 25,700 HKD, with a price ranging from 0.1650 to 0.1760 HKD per share.These transactions were carried out before a possible mandatory general offer period and are classified as activities related to existing derivative instruments or options traded on the Exchange. MSHK, representing MSAP, is categorized as a type (5) connected person with a relationship to the offer company, and the transactions were conducted for its own account. It is noteworthy that both MSHK and MSAP are ultimately owned by Morgan Stanley.

On January 3, 2025, Morgan Stanley Asia Limited (MSAP) conducted a transaction of derivative warrants for PA GOODDOCTOR (Ping An Health Medical Technology Co., Ltd.) through Morgan Stanley Hong Kong Limited (MSHK). As a designated market maker approved by the Hong Kong Stock Exchange, MSHK sold 100,000 shares on behalf of MSAP for a total amount of 16,500 HKD, with a price of 0.1650 HKD per share; at the same time, it bought 152,000 shares for a total amount of 25,700 HKD, with a price ranging from 0.1650 to 0.1760 HKD per share.These transactions were carried out before a possible mandatory general offer period and are classified as activities related to existing derivative instruments or options traded on the Exchange. MSHK, representing MSAP, is categorized as a type (5) connected person with a relationship to the offer company, and the transactions were conducted for its own account. It is noteworthy that both MSHK and MSAP are ultimately owned by Morgan Stanley.